SCHEMBL10112002

SCHEMBL10112002

Fc1ccc(Cl)c(N2CCC3(CC2)CNC3)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.47
ADRA1A P35348 1/20 0.47
ADRA1B P35368 1/20 0.47
SLC6A2 P23975 5/20 0.42
SLC6A4 P31645 5/20 0.42
SLC6A3 Q01959 5/20 0.42
HRH3 Q9Y5N1 1/20 0.40
FFAR4 Q5NUL3 7/20 0.39
FFAR1 O14842 1/20 0.38
SCD O00767 1/20 0.38
SCD5 Q86SK9 1/20 0.38
NAMPT P43490 1/20 0.37
DRD3 P35462 1/20 0.37
ADRB1 P08588 1/20 0.37
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1394006 0.90 FFAR4 (0.45) HTR1AADRA1AADRA1BFFAR4FFAR1
SCHEMBL10112057 0.84 HTR1A (0.41) HTR1AADRA1AADRA1BSLC6A2SLC6A4
SCHEMBL31342232 0.81 HRH3 (0.39) HTR1AADRA1BSLC6A2SLC6A4SLC6A3
SCHEMBL6195922 0.79 ADRB1 (0.59) HTR1ASLC6A2SLC6A4SLC6A3DRD3
Hydrochloric Acid SCHEMBL3710005 0.78 ADRB1 (0.58) HTR1ASLC6A2SLC6A4SLC6A3DRD3
Trifluoroacetic Acid SCHEMBL1394390 0.77 SCD (0.42) HTR1AADRA1AADRA1BFFAR4FFAR1
SCHEMBL31341868 0.77 SLC6A2 (0.43) HTR1AADRA1AADRA1BSLC6A2SLC6A4
SCHEMBL30553399 0.77 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3HRH3FFAR4
SCHEMBL25943495 0.77 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3HRH3FFAR4
SCHEMBL1394929 0.76 SCD (0.47) HTR1AADRA1AADRA1BFFAR4FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120010186-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2012-01-12 US disclosed
US-20120010186-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2012-01-12 US disclosed
WO-2010108268-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010186-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, FASN HTR1A 3688/4885ADRA1A 3110/4885ADRA1B 3580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.